nivolumab,ipilimumab,cabozantinib
bms,ipsen
['rcc,(-irccs),(-srcc),(-urcc)', 'cabozantinib', 'so proud', ' ipi ', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'cabopoint', 'nivo']
so proud of et al for cabopoint. there is definite activity of cabozantinib in #rcc post ipi nivo or io vegf therapy. #gu23 
A medical oncologist that specializes in and focuses his research on urologic cancers.